IL PORTALE per la RICERCA dei DIPARTIMENTI

Ferorelli S (2012) "2-Aminopyiridine derivatives as potential sigma 2 receptor antagonists"

Niso M (2012) "2-Aminopyridine Derivatives as Potential sigma 2 Receptor Antagonists"

Abate C (2012) "2-Aminopyridine Derivatives as Potential s(2) Receptor Antagonists."

Perrone R (2012) "2-Aminopyridine Derivatives as Potential s2 Receptor Antagonists"

BERARDI F (2012) "2-Aminopyridine derivatives as potential sigma2 receptor antagonists"

ALTOMARE C. (2012) "2-Benzazepine Nitrones Protect Dopaminergic Neurons Against 6-Hydroxydopamine-Induced Oxidative Toxicity"

de Candia M (2012) "2-Benzazepine Nitrones Protect Dopaminergic Neurons against 6-Hydroxydopamine-Induced Oxidative Toxicity"

ARMENISE D (2012) "4H-1,4-Benzothiazine, Dihydro-1,4-benzothiazinones and 2-Amino-5-fluorobenzenethiol Derivatives: Design, Synthesis and in vitro Antimicrobial Screening"

DE LAURENTIS N (2012) "4H-1,4-Benzothiazine, Dihydro-1,4-benzothiazinones and 2-Amino-5-fluotobenzenethiol Derivatives: Design, Synthesis and nin vitro Antimicrobial Screening"

Carrieri A (2012) "4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5-fluorobenzenethiol derivatives: design, synthesis and in vitro antimicrobial screening"

FRANCHINI C (2012) "4H-1,4-benzothiazine, dihydro-1,4-benzothiazones and 2-amino-5-fluorobenzenethiol derivates: design,synthesis and in vitro"

Corbo F (2012) "4H-1,4-benzothiazine, dihydro-1,4-benzothiazones and 2-amino-5-fluorobenzenethiol derivates: design,synthesis and in vitro antimicrobial screening"

BERARDI F (2012) "A benzopyrane derivative as P-glycoprotein stimulator: a potential agent to decrease beta-amyloid accumulation in Alzheimer’s Disease"

Leopoldo M (2012) "A Benzopyrane Derivative as a P-Glycoprotein Stimulator: A Potential Agent to Decrease b-Amyloid Accumulation in Alzheimer’s Disease"

Capparelli E (2012) "A Benzopyrane Derivative as a P-Glycoprotein Stimulator: A Potential Agent to Decrease ß-Amyloid Accumulation in Alzheimer's Disease"

Perrone M.G. (2012) "A Benzopyrane derivative as P-glycoprotein stimulator: a potential agent to decrease beta-amyloid accumulation in Alzheimer’s disease"

Niso M (2012) "A Benzopyrane derivative as P-glycoprotein stimulator: a potential agent to decrease ß-amyloid accumulation in Alzheimer’s disease"

Perrone R (2012) "A benzopyrane derivative as a P-glycoprotein stimulator: a potential agent to decrease beta-amyloid accumulation in Alzheimer's disease"

Colabufo N (2012) "A benzopyrane derivative as a P-glycoprotein stimulator: a potential agent to decrease ¿-amyloid accumulation in Alzheimer's disease"

Nicolotti O (2012) "A chemocentric approach to the identification of cancer targets"

Carotti A (2012) "A chemocentric approach to the identification of cancer targets."

AVATO P (2012) "A comparison of headspace solid-phase microextraction and classic hydrodistillation for the identification of volatile constituents from Thapsia spp. provides insights into guaianolide biosynthesis in Apiaceae"

Leopoldo M (2012) "Activatable Fluorescent Probes: A New Concept in Optical Molecular Imaging"

Lacivita E (2012) "Activatable Fluorescent Probes: A New Concept in Optical Molecular Imaging"

Colabufo N (2012) "Activatable fluorescent probes: a new concept in optical molecular imaging"

Perrone R (2012) "Activatable fluorescent probes: a new concept in optical molecular imaging"

BERARDI F (2012) "Activatable fluorescent probes: a new concept in optical molecular imaging."

Leopoldo M (2012) "Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X Syndrome"

Lacivita E (2012) "Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X Syndrome"

FRANCHINI C (2012) "Activity of natural hydroxytyrosol versus a synthestic sample and its chiral analogues: hypothesis of mechanism of action"

Conte D (2012) "Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission"

Desaphy J.-F. (2012) "Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission"

CAVALLUZZI M (2012) "An Improved Synthesis of m-Hydroxymexiletine, a Potent Mexiletine Metabolite "

CAROCCI A (2012) "An Improved Synthesis of m-Hydroxymexiletine, a Potent Mexiletine Metabolite"

FRANCHINI C (2012) "An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite"

CATALANO A (2012) "An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite"

Defrenza I (2012) "An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite"

LENTINI G (2012) "An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite"

FRANCHINI C (2012) "Aromatic garlands, as new foldamers, to mimic protein secondary structure"

CONTINO M (2012) "Benzopyrane derivative as P-glycoprotein stimulator: a potential agent to decrease Beta-amyloid accumulation in Alzheimer’s disease"

AVATO P (2012) "Bioactive compounds from Capparis spinosa subsp. rupestris"

Carotti A (2012) "Building up QSAR model for toxicity of Psycotropic Drugs by the Monte Carlo Method."

TRAPANI A (2012) "C i p ro f l o x a c i n - l o a d e d C h i t o s a n Nanoparticles as Titanium Coatings: A Valuable Strategy to Prevent Implant associated Infections "

ABATE C (2012) "CLASSES OF SIGMA2 (s2) RECEPTOR LIGANDS: STRUCTURE AFFINITY RELATIONSHIP (SAfiR) STUDIES and ANTIPROLIFERATIVE ACTIVITY "

MANGIATORDI G (2012) "Charge transport in poly-imidazole membranes: a fresh appraisal of the Grotthuss mechanism"

Perrone R (2012) "Classes of Sigma-2 receptor ligands: structure affinity relatioship studies and antiproliferative activity"

BERARDI F (2012) "Classes of sigma2 ( o-2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity"

LENTINI G (2012) "Crystal structure of N-(2-{[(2E)-3-(4-chlorophenyl)-2-propenyl]- (methyl)ammonio}methylphenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide dihydrogenphosphate — methanol (1:1), [C26H30ClN2SO4][H2PO4] × CH4O"

MANGIATORDI G (2012) "DFT and Proton Transfer Reactions: A Benchmark Study on Structure and Kinetics"

Stefanachi A (2012) "Design, Synthesis, and Biological Evaluation of 2-Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors"

Cellamare S (2012) "Design, synthesis and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors"

Cellamare S (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Tortorella P (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Nicolotti O (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Catto M (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9."

Pisani L (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9."

LOIODICE F (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9."

Leonetti F (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substitutedpyrimidine- 2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Stefanachi A (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substitutedpyrimidine- 2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Carotti A (2012) "Design, synthesis and biological evaluation of 5-hydroxy, 5-substitutedpyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9"

Carotti A (2012) "Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase"

Catto M (2012) "Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase"

Campagna F (2012) "Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterases"

Vitale P (2012) "Diarylheterocycle Core Ring Features Effect in Selective COX-1 Inhibition"

Perrone M.G. (2012) "Diarylheterocycles core ring feature effect in selective COX-1 inhibition"

Scilimati A (2012) "Diarylheterocycles core ring features effect in selective COX-1 inhibition"

Denora N (2012) "Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs"

Cozzoli A (2012) "Disease-related modification of chloride conductance in skeletal muscle of dystrophic mice: expression of CLC-1 channel and role of inflammation and oxidative stress-related signaling"

Lograno M.D. (2012) "Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats."

DE LUCA A (2012) "Enhancing translation: Guidelines for standard pre-clinical experiments in mdx mice"

CATTO M (2012) "Estimation of the Binding Free Energy by Linear Interaction Energy Models"

Leonetti F (2012) "Estimation of the Binding Free Energy by Linear Interaction Energy Models"

Cellamare S (2012) "Estimation of the Binding Free Energy by Linear Interaction Energy Models"

Nicolotti O (2012) "Estimation of the Binding Free Energy by Linear Interaction Energy Models"

Carotti A (2012) "Estimation of the binding free energy by linear interaction energy models"

PERNA F (2012) "Exploiting the Lithiation-Directing Ability of Oxetane for the Regioselective Preparation of Functionalized 2-Aryloxetane Scaffolds under Mild Conditions"

Capriati V (2012) "Exploiting the Lithiation-Directing Ability of Oxetane for the Regioselective Preparation of Functionalized 2-Aryloxetane Scaffolds under Mild Conditions"

Capriati V (2012) "Exploiting the Lithiation-Directing Ability of Oxetane for the Regioselective Preparation of Functionalized 2-Aryloxetane Scaffolds under Mild Conditions"

Lacivita E (2012) "Fluorescent probes: from bench to bedside"

FRACCHIOLLA G (2012) "Frontal affinity chromatography with MS detection of the ligand binding domain of PPARgamma receptor: Ligand affinity screening and stereoselective ligand–macromolecule interaction"

Antonio Laghezza (2012) "Frontal affinity chromatography with MS detection of the ligand binding domain of PPAR¿ receptor: Ligand affinity screening and stereoselective ligand–macromolecule interaction"

LOIODICE F (2012) "Frontal affinity chromatography with MS detection of the ligand binding domain of PPAR¿ receptor: ligand affinity screening and stereoselective ligand–macromolecule interaction."

TRAPANI A (2012) "In vitro evaluation on a model of Blood Brain Barrier of Idebenone loaded solid lipid nanoparticles."

Latrofa A (2012) "In vitro evaluation on a model of Blood Brain Barrier of Idebenone-loaded solid lipid nanoparticles"

ANTONIO ROSATO (2012) "In vitro synergy testing of Anidulafungin with Fluconazole, Tioconazole, 5-Flucytosine and Amphotericin B against some Candida spp."

Corbo F (2012) "In vitro synergy testing of anidulafungin with Fluconazole, Tioconazole, 5-Flucytosine and Amphotericin B against some Candida app."

FRANCHINI C (2012) "In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp"

Lopedota A (2012) "In vivo administration of CLC-K Kidney chloride inhibitors increases water diuresis in rats: a new drug target of hypertension?"

Perrone M.G. (2012) "In vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?"

CONTE D (2012) "In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?"

Liantonio A (2012) "In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension? "

LOIODICE F (2012) "In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?"

Antonio Laghezza (2012) "In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?"

Fracchiolla G (2012) "In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension? "

Nicolotti O (2012) "Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity"

Catto M (2012) "Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: Proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumour activity"

Carotti A (2012) "Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity"

Perrone R (2012) "Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the 5-HT7 Receptor with Agonist or Antagonist Action in Vitro or ex Vivo."

Colabufo N (2012) "Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the 5-HT7 Receptor with Agonist or Antagonist Action in Vitro or ex Vivo. "

Lacivita E (2012) "Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin (5-HT7) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo "

Di Pilato P (2012) "Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin(7) (5-HT(7)) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo."

Leopoldo M (2012) "Investigations on the 1-(2-biphenyl)piperazine motif. Identification of new potent and selective ligands for the serotonin7 (5-HT7) receptor with agonist or antagonist ac-tion in vitro or ex vivo."

CONTINO M (2012) "Investigations on the 1-(2-biphenyl)piperazine motif. Identification of new potent and selective ligands for the serotonin7 (5-HT7) receptor with agonist or antagonist action in vitro or ex vivo"

BERARDI F (2012) "Investigations on the 1-(2-biphenyl)piperazine motif. Identification of new potent and selective ligands for the serotonin7 (5-HT7) receptor with agonist or antagonist action in vitro or ex vivo."

Niso M (2012) "Investigations on the 1-(2-biphenyl)piperazine motif: Identification of new potent and selective ligands for the serotonin7 (5-HT7) receptor with agonist or antagonist action in vitro or ex vivo"

LOGRANO M.D. (2012) "Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery."

Imbrici P (2012) "Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature"

LENTINI G (2012) "Le proprietà antiossidanti dell'Uva di Troia Canosina ad Acino Piccolo: confronto tra differenti metodi estrattivi"

Abate C (2012) "Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer "

BERARDI F (2012) "Lysosomial membrane permeabilization is an early event in sigma-2 receptor ligand mediated cell death in pancreatic cancer"

Leopoldo M (2012) "Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: Site-dependent effects on REM sleep"

FRACCHIOLLA G (2012) "Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?"

Carbonara G (2012) "Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?"

Carrieri A (2012) "Might the observed a(2A)-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?"

LACIVITA E (2012) "Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice"

Conte D (2012) "Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine."

CATALANO A (2012) "Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine"

Desaphy J.-F. (2012) "Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine"

LENTINI G (2012) "Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine"

CAROCCI A (2012) "Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine"

FRANCHINI C (2012) "Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine"

Catto M (2012) "New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia"

ALTOMARE C. (2012) "New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia"

Stefanachi A (2012) "New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia"

Nicolotti O (2012) "New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia"

Carotti A (2012) "New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia."

CELLAMARE S (2012) "New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in Chronic Myeloid Leukemia"

Leonetti F (2012) "New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in chronic myeloid leukemia."

TRAPANI G (2012) "Novel codrugs with GABAergic activity for dopamine delivery in the brain"

Trapani A (2012) "Novel codrugs with GABAergic activity for dopamine delivery in the brain"

LAQUINTANA V (2012) "Novel codrugs with GABAergic activity for dopamine delivery in the brain"

Denora N (2012) "Novel codrugs with GABAergic activity for dopamine delivery in the brain "

VITALE P (2012) "Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells"

SCILIMATI A (2012) "Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells"

Perrone M.G. (2012) "Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells."

LUISI R (2012) "One-pot preparation of piperazines by regioselective ring-opening of non activated arylaziridines"

DEGENNARO L (2012) "One-pot preparation of piperazines by regioselective ring-opening of non-activated arylaziridines"

Conte D (2012) "Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels."

Mele A (2012) "Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels"

Tricarico D (2012) "Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels "

AVATO P (2012) "Phytochemical analysis of a herbal tea from Artemisia annua"

ARGENTIERI M (2012) "Phytochemical analysis of a herbal tea from Artemisia annua L."

LENTINI G (2012) "Phytochemical, Antioxidant and Anti-a-glucosidase Activity Evaluations of Bergenia cordifolia"

Carotti A (2012) "Potent Galloyl-Based Selective Modulators Targeting Multidrug Resistance Associated Protein 1 and P-glycoprotein"

Nicolotti O (2012) "Potent Galloyl-Based Selective Modulators Targeting Multidrug Resistance Associated Protein 1 and P-glycoprotein"

CELLAMARE S (2012) "Potent galloyl-based selective modulators of Multidrug Resistance-Associated Protein 1 and P-glycoprotein"

Stefanachi A (2012) "Potent galloyl-based selective modulators of Multidrug Resistance-Associated Protein 1 and P-glycoprotein."

Niso M (2012) "Potent galloyl-based selective modulators targeting Multidrug Resistance Associated Protein 1 and P-glycoprotein"

Colabufo N (2012) "Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein"

BERARDI F (2012) "Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein."

Leonetti F (2012) "Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein."

Perrone R (2012) "Potent galloyl-based selective modulatorstargeting multidrug resistence associated protein 1 and P-glycoprotein"

Conte D (2012) "Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat"

Pierno S (2012) "Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat"

Liantonio A (2012) "Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat."

DESAPHY J.-F. (2012) "Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat"

Cannone M (2012) "Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat"

DE BELLIS M (2012) "Potential bene¿ts of taurine in the prevention of skeletal impairment induced by disuse in the hindlimb-unloaded rat"

DE LUCA A (2012) "Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview"

TRAPANI G (2012) "Recent advances in ligand targeted therapy"

LAQUINTANA V (2012) "Recent advances in ligand targeted therapy"

Denora N (2012) "Recent advances in ligand targeted therapy"

TRAPANI A (2012) "Recent advances in ligand targeting therapy"

CORBO F (2012) "SEARCHING FOR NOVEL ANTI-MYOTONIC AGENTS: PHARMACOPHORE REQUIREMENT FOR USE-DEPENDENT BLOCK OF SKELETAL MUSCLE SODIUM CHANNELS BY N-BENZYLATED CYCLIC DERIVATIVES OF TOCAINIDE"

CAROCCI A (2012) "Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

CONTE D (2012) "Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

DE LUCA A (2012) "Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

FRANCHINI C (2012) "Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

CATALANO A (2012) "Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

DE BELLIS M (2012) "Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide"

LENTINI G (2012) "Shouldn’t enantiomeric purity be included in the ‘minimum information about a bioactive entity’?"

Tricarico D (2012) "Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle"

Conte D (2012) "Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle."

CAROCCI A (2012) "Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers"

Defrenza I (2012) "Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers"

LENTINI G (2012) "Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers. "

CATALANO A (2012) "Stereospecific synthesis of m-hydroxymexiletine enantiomers"

FRANCHINI C (2012) "Stereospecific synthesis of m-hydroxymexiletine enantiomers"

Pisani L (2012) "Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia."

Mele A (2012) "Structural Nucleotide Analogs are Potent Activators/Inhibitors of Pancreatic Beta-Cell KATP Channels: an Emerging Mechanism Supporting Their Use as Anti-Diabetic Drugs"

Tricarico D (2012) "Structural Nucleotide Analogs are Potent Activators/Inhibitors of Pancreatic Beta-Cell KATP Channels: an Emerging Mechanism Supporting Their Use as Anti-Diabetic Drugs"

FRACCHIOLLA G (2012) "Structural Nucleotide Analogs are Potent Activators/Inhibitors of Pancreatic Beta- Cell KATP Channels: an Emerging Mechanism Supporting Their Use as Anti- Diabetic Drugs"

ANTONIO LAGHEZZA (2012) "Structural Nucleotide Analogs are Potent Activators/Inhibitors of Pancreatic Beta-Cell KATP Channels: an Emerging Mechanism Supporting Their Use as Anti-Diabetic Drugs"

CARBONARA G (2012) "Structural Nucleotide Analogs are Potent Activators/Inhibitors of Pancreatic Beta-Cell KATP Channels: an Emerging Mechanism Supporting Their Use as Anti-Diabetic Drugs"

Tortorella P (2012) "Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs."

LOIODICE F (2012) "Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs."

Conte D (2012) "Structural nucleotide analogs are potent activators/inhibitors of pancreatic ß cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs"

LENTINI G (2012) "Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels"

FRANCHINI C (2012) "Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels"

CAROCCI A (2012) "Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels"

Perrone M.G. (2012) "Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels"

Capparelli E (2012) "Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113"

Colabufo N (2012) "Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113."

CATALANO A (2012) "Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels"

Colabufo N (2012) "Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels"

Conte D (2012) "Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels"

Desaphy J.-F. (2012) "Synthesis and toxicopharmacological evaluation of meta-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels"

FRACCHIOLLA G (2012) "Synthesis, Characterization and Biological Evaluation of Ureidofibrate-Like Derivatives Endowed with Peroxisome Proliferator-Activated Receptor Activity"

Antonio Laghezza (2012) "Synthesis, Characterization and Biological Evaluation of Ureidofibrate-Like Derivatives Endowed with Peroxisome Proliferator-Activated Receptor Activity"

Carotti A (2012) "Synthesis, and Biological Evaluation of 2-Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors."

FRACCHIOLLA G (2012) "Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists"

Tortorella P (2012) "Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists"

Carbonara G (2012) "Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists"

LOIODICE F (2012) "Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists."

Antonio Laghezza (2012) "Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors a/¿ dual agonists"

LOIODICE F (2012) "Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity."

Tortorella P (2012) "Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity."

Mantuano P (2012) "Synthetic lethality to overcome cancer drug resistance"

Coluccia M (2012) "The IS-BioBank Project: A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis"

ABATE C (2012) "The sigma-1 receptor antagonist PB212 reduces the Ca(2+)-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells."

BERARDI F (2012) "The sigma-1 receptor antagonist PB212 reduces the Ca2+-release through the inositol (1, 4, 5)-triphosphate receptor in SK-N-SH cells"

Mele A (2012) "The splicing of the rSlo gene affects molecular composition and drug response of Ca2+activated K+channels in skeletal muscle: implications for therapy"

CATALANO A (2012) "The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism"

Lacivita E (2012) "The therapeutic potential of 5-HT1A receptors: a patent review"

Colabufo N (2012) "The therapeutic potential of 5-HT1A receptors: a patent review"

BERARDI F (2012) "The therapeutic potential of 5-HT1A receptors: a patent review"

Di Pilato P (2012) "The therapeutic potential of 5-HT1A receptors: a patent review."

Perrone R (2012) "The therapeutic potential of 5-HT1A receptors: a patent review."

Leopoldo M (2012) "The therapeutic potential of 5-HT1A receptors; a patent review"

Nicolotti O (2012) "Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams"

Stefanachi A (2012) "Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams"

Leonetti F (2012) "Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams"

Pisani L (2012) "Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams."

Carotti A (2012) "Towards a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams "

Cellamare S (2012) "Towards a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams."

Catto M (2012) "Towards a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams."

ALTOMARE C. (2012) "beta-D-Glucosyl Conjugates of Highly Potent Inhibitors of Blood Coagulation Factor Xa Bearing 2-Chorothiophene as P1 Motif"

de Candia M (2012) "beta-D-glucosyl conjugates of highly potent inhibitors of blood coagulation factor Xa bearing 2-chlorothiophene as a P1 motif"

Lograno M.D. (2012) "ß-D-Glucosyl Conjugates of Highly Potent Inhibitors of Blood Coagulation Factor Xa Bearing 2-Chorothiophene as a P1 Motif"

CAMPAGNA F (2012) "ß-D-Glucosyl Conjugates of Highly Potent Inhibitors of Blood Coagulation Factor Xa Bearing 2-Chorothiophene as a P1 Motif"

LENTINI G (2012) "Activity of natural hydroxytyrosol versus a synthetic sample and its chiral analogues: Hypothesis on mechanism of action "

Desaphy J.-F. (2012) "Biophysical characterization of hClC-1 chloride channel mutations associated with myotonia congenita"

Desaphy J.-F. (2012) "Characterization of the role of PKC-theta in the modulation of ClC-1 chloride channel function and calcium homeostasis in fast and slow-twitch skeletal muscle by using PKC-theta null mice"

De Bellis M (2012) "Characterization of the role of PKC-theta in the modulation of ClC-1 chloride channel function and calcium homeostasis in fast and slow-twitch skeletal muscle by using PKC-theta null mice"

Liantonio A (2012) "Characterization of the role of PKC-theta in the modulation of ClC-1 chloride channel function and calcium homeostasis in fast and slow-twitch skeletal muscle by using PKC-theta null mice"

Conte D (2012) "Characterization of the role of PKC-theta in the modulation of ClC-1 chloride channel function and calcium homeostasis in fast and slow-twitch skeletal muscle by using PKC-theta null mice"

De Luca A (2012) "Disease-Related Modification of Chloride Conductance in Skeletal Muscle of Dystrophic Mice: Expression of CLC-1 Channel and Role of Inflammation and Oxidative Stress-Related Signaling"

Capogrosso R (2012) "Disease-related modification of chloride conductance in skeletal muscle of dystrophic mice: expression of CLC-1 channel and role of inflammation and oxidative stress-related signaling."

Desaphy J.-F. (2012) "Effect of pleiotrophin overexpression on ion channel function/expression in mouse soleus muscle after hindlimb unloading"

CAVALLUZZI M (2012) "Molecular Determinants of Human Voltage-Gated Sodium Channels Blockade by Lubeluzole"

Desaphy J.-F. (2012) "Molecular determinants of human voltage-gated sodium channel blockade by lubeluzolE"

LENTINI G (2012) "Molecular determinants of human voltage-gated sodium channel blockade by lubeluzole"

Conte D (2012) "Molecular determinants of human voltage-gated sodium channel blockade by lubeluzole"

Cozzoli A (2012) "Parallel effects of a-methyl-prednisolone on skeletal muscle and brain of mdx mice: Identification of a novel mechanism of action"

Capogrosso R (2012) "Parallel effects of a-methyl-prednisolone on skeletal muscle and brain of mdx mice: Identification of a novel mechanism of action."

De Luca A (2012) "Parallel effects of a-methyl-prednisolone on skeletal muscle and brain of mdx mice: Identification of a novel mechanism of action."